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Summary
Epigenetic changes, including histone methylation, control T cell differentiation and memory 
formation, though the enzymes that mediate these processes are not clear. We show that UTX, a 
histone H3 lysine 27 (H3K27) demethylase, supports T follicular helper (Tfh) cell responses that 
are essential for B cell antibody generation and the resolution of chronic viral infections. Mice 
with a T cell-specific UTX deletion had fewer Tfh cells, reduced germinal center responses, 
lacked virus-specific IgG, and were unable to resolve chronic lymphocytic choriomeningitis virus 
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infections. UTX-deficient T cells showed decreased expression of interleukin-6 receptor-α and 
other Tfh cell-related genes that were associated with increased H3K27 methylation. Additionally, 
Turner Syndrome subjects, who are predisposed to chronic ear infections, had reduced UTX 
expression in immune cells and decreased circulating CD4+ CXCR5+ T cell frequency. Thus, we 
identify a critical link between UTX in T cells and immunity to infection.
Graphical Abstract
Introduction
Hundreds of millions of people worldwide are infected with viruses that persist and induce 
devastating diseases (Virgin et al., 2009). Viruses such as HIV, HCV, and HBV establish 
chronic infections when the adaptive immune response initially fails to eliminate them. Over 
time, extended exposure to viral antigens and sustained inflammation further diminishes the 
T cell response. In contrast to acute infections, where highly functional memory T cells form 
following transient expansion and contraction phases, chronic infections lead to virus 
specific CD8+ T cell exhaustion, in which cells are physically depleted or functionally 
inactivated (Wherry, 2011). Overcoming T cell exhaustion in persistent viral infection is a 
potential approach to enhance the antiviral immune response.
CD4+ T cells support CD8+ T cell responses and preferentially differentiate into the T 
follicular helper (Tfh) cell subset during chronic viral infections (Brooks et al., 2005; Fahey 
et al., 2011; Matloubian et al., 1994; Thomsen et al., 1996). This increase in Tfh cell 
differentiation is enhanced by the repetitive T cell receptor (TCR) activation that occurs 
during persistent infection (Fahey et al., 2011). As a result, increased populations of virus-
specific Tfh cells are observed during chronic lymphocytic choriomeningitis virus (LCMV) 
infection of mice, as well as HIV, HBV, and HCV infections of humans (Fahey et al., 2011; 
Feng et al., 2012; Feng et al., 2011; Lindqvist et al., 2012). Tfh cells upregulate CXCR5, 
which enables them to relocate to B cell areas of lymphoid organs. Tfh cells interact with B 
cells to generate plasmablasts or enter germinal centers (GCs) to drive B cell proliferation, 
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antibody affinity maturation, isotype class switching, and the formation of memory B cells 
and plasma cells (Crotty, 2011). The shift toward CD4+ Tfh cell differentiation is 
functionally important because B cells and antibody production are crucial for eventual virus 
control in mouse models of chronic infection (Bergthaler et al., 2009; Planz et al., 1997). 
CD4+ Tfh cells also produce IL-21, a cytokine that sustains CD8+ T cells during chronic 
viral infections (Elsaesser et al., 2009; Frohlich et al., 2009; Yi et al., 2009). The importance 
of Tfh cells may be conserved in humans, as a distinct population of circulating memory Tfh 
cells correlates with broadly neutralizing antibodies against HIV (Locci et al., 2013). 
Although IL-6 production by follicular dendritic cells is required for Tfh cell responses and 
control of chronic LCMV infection (Harker et al., 2011), how virus persistence advances 
Tfh differentiation is not understood.
The differentiation of CD4+ T helper (Th) cells into distinct lineages correlates with specific 
epigenetic modifications (Wei et al., 2009; Wilson et al., 2009). These epigenetic changes 
include post-translational histone methylation, which modulate nucleosome structure to 
regulate transcription factor accessibility. For example, H3K27me3 contributes to repressive 
chromatin and gene silencing, while histone H3 lysine 4 trimethylation (H3K4me3) is 
indicative of genes that are actively transcribed (Bannister and Kouzarides, 2011). The 
H3K27 methyltransferase Enhancer of Zeste Homolog 2 (EZH2) regulates Th1 and Th2 
differentiation, and EZH2 deficiency enhances interferon gamma (IFN-γ) and IL-4 
production in vitro and allergic asthma pathology in vivo (Tumes et al., 2013). In these 
models, EZH2-mediated trimethylation of H3K27 represses gene expression and restricts the 
differentiation of Th progenitor cells. However, which histone demethylases promote Th 
lineage differentiation in vivo is not known.
UTX (ubiquitously transcribed tetratricopeptide repeat, X chromosome; KDM6A), along 
with UTY and JMJD3 (KDM6B), are members of an evolutionarily conserved, Jumonji-C 
(JmjC) domain containing family of H3K27me3 demethylases (Agger et al., 2007). Utx is 
widely expressed and has functions in biological processes ranging from embryonic 
development to tumor suppression, and homozygous Utx mutations in the mouse are 
embryonic lethal (Shpargel et al., 2012). In this study, we generated T cell-specific UTX-
deficient (UTX-TCD) mice to assess the in vivo effects of UTX on T cell activation and 
differentiation during acute and chronic virus infection. Our results indicate that UTX is 
required for optimal CD4+ T cell differentiation to Tfh cells during chronic, but not acute, 
virus infection. Moreover, UTX-TCD mice showed defects in germinal center formation, 
virus-specific IgG production, and clearance of a chronic viral infection. UTX deficiency 
resulted in increased H3K27 methylation and decreased expression at Il6ra and other Tfh-
related genetic loci. Furthermore, human Turner Syndrome subjects with decreased UTX 
expression in peripheral blood also demonstrated decreased numbers of circulating CD4+ 
CXCR5+ T cells. These results delineate a link between a histone demethylase in T cells and 
immunity to chronic virus infection.
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Lack of T cell UTX does not alter clearance of acute viral infection
To study the role of UTX in T cells, we generated T cell-specific UTX-deficient mice by 
crossing the Utxfl line, which harbors a floxed third exon, with mice expressing Cre 
recombinase under the control of the T cell-specific Lck promoter. Females with a Cre-
mediated Utx deletion in T cells (Utxfl/fl; Lck-Cre), hereafter referred to as UTX-TCD (T 
cell deficient), were born at expected frequencies and matured to adulthood. A T cell-
specific decrease of UTX protein was confirmed by western blotting of sorted splenocytes 
from UTX-TCD mice relative to Utxfl/fl controls (referred to as WT) (Figure S1A). We first 
evaluated the role of UTX in T cell thymic development and peripheral maintenance under 
homeostatic conditions. In 6 week-old UTX-TCD mice, CD4+ and CD8+ T cell 
development was unchanged in the thymus, while modest decreases in CD4+ and CD8+ T 
cell frequencies and numbers were noted in the spleen (Figure S1B,C). Given the modest 
decrease in peripheral CD4+ and CD8+ T cells, we assessed the proliferative capacity of 
UTX-deficient T cells by stimulating CFSE-labeled splenocytes with plate-bound anti-CD3 
and anti-CD28 antibodies. We detected equivalent cell division between WT and UTX-TCD 
CD4+ and CD8+ T cells across a range of anti-CD3 concentrations (Figure S1D). Thus, the 
T cell-specific deletion of UTX results in moderate decreases in CD4+ and CD8+ T cell 
numbers without affecting their proliferative response to in vitro TCR stimulation.
To assess the functional consequence of T cell UTX deficiency during an in vivo immune 
response, we infected UTX-TCD mice with the Armstrong strain of LCMV, which causes 
an acute infection that is cleared within a week by CD8+ T cells in WT mice independently 
of CD4+ T cells. In UTX-TCD mice, the loss of UTX had a minimal effect on virus 
clearance; 6 of 7 UTX-TCD mice resolved the infection by day 8 and only one mouse 
showed a low level of virus at this time (Figure S2A). Tetramer staining revealed that the 
total numbers of LCMV-specific Db/GP33-41+ CD8+ and I-Ab/GP66-77+ CD4+ T cells 8 
days after infection were unaffected by the absence of UTX (Figure S2B). Furthermore, the 
total numbers of cytokine producing CD8+ and CD4+ T cells 8 days post infection (pi) were 
unchanged in the UTX-TCD mice (Figures S2C & S2D). These data show that virus-
specific UTX-deficient T cells accumulate and function normally following acute infection. 
Furthermore, the numbers of cytokine-producing memory T cells at day 66 pi were not 
altered in the UTX-TCD mice (Figures S2E & S2F). Thus, despite reductions in peripheral 
T cell numbers under homeostatic conditions (Fig S1B-C), these reductions can be 
overcome since UTX-TCD mice generate protective antiviral responses following an acute 
viral infection.
T cell UTX is required for clearance of chronic viral infection
In contrast to the Armstrong strain, the A22 strain of LCMV establishes a chronic infection 
that typically persists for 1-2 months in WT mice (van der Most et al., 1996; Whitmire et al., 
2009). Whereas clearance of the Armstrong strain of LCMV is solely dependent on CD8+ T 
cells, the eventual clearance of persistent LCMV strains, including A22, depends on CD8+ T 
cells, CD4+ T cells, and B cells (Bergthaler et al., 2009; Matloubian et al., 1994; Planz et al., 
1997). Given the different immune effector requirements for clearing chronic infection, we 
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tested the effects of T cell specific UTX deficiency on the control of persistent LCMV-A22 
infection. There was a delay in the clearance of LCMV-A22 from the serum of the UTX-
TCD mice (Figure 1A). The initial levels of virus in the serum were equivalent in the two 
groups, but the WT animals subsequently eliminated the infection while the UTX-TCD mice 
did not (Figure 1A). The virus levels in the liver, lung, and kidney were all higher at day 66 
pi in the UTX-TCD mice compared to WT mice (Figure 1B).
Because CD4+ and CD8+ T cells are required to eliminate chronic LCMV infection, we 
examined whether UTX deficiency affects virus-specific CD4+ and/or CD8+ T cell 
responses. Given that antiviral T cells are affected by viral loads during the chronic stage 
(Fahey et al., 2011; Fuller and Zajac, 2003; Mueller and Ahmed, 2009; Zajac et al., 1998), 
we analyzed T cell responses at day 21 pi, when virus levels were equivalent between the 
WT and UTX-TCD mice. At this time point, any alterations in the T cell responses should 
be independent of the secondary effects caused by variations in virus load. We did not detect 
any difference in the frequency or number of tetramer positive UTX-TCD CD8+ T cells at 
this time point compared to infected WT mice (Figure 1C). Furthermore, there was no 
difference in CD8+ T cell expression of the “exhaustion” markers, PD-1 and Lag-3 
(lymphocyte activation gene-3 or CD223) (Figure 1D). Although CD8+ T cell responses 
were largely unchanged, UTX-TCD mice demonstrated a reduced frequency and number of 
LCMV-specific antiviral CD4+ T cells at day 21 (Figure 1E). These data indicate that T cell 
expression of UTX is critical for the clearance of a chronic virus infection and raise the 
possibility that UTX directly regulates CD4+ T cell responses.
CD4+ Tfh cell numbers and function are decreased in UTX-TCD mice
CD4+ T cells and antibody production by B cells are crucial for resolving chronic viral 
infections (Bergthaler et al., 2009; Planz et al., 1997; Richter and Oxenius, 2013). There is 
an increase in CD8+ T cell exhaustion and delayed virus clearance when CD4+ T cells are 
depleted during chronic LCMV infection (Matloubian et al., 1994). During these chronic 
infections, CD4+ T cells preferentially differentiate into Tfh cells, which upregulate 
CXCR5, migrate into B cell follicles, interact with B cells at germinal centers (GC), and 
promote the production of antibodies (Crotty, 2011). During these T-B interactions within 
the GCs, B cells proliferate, mutate their antibody genes, and undergo immunoglobulin class 
switching; these events are important in the production of protective antibody responses. 
Based on this and the observed overall reduction in CD4+ T cells, we hypothesized that T 
cell UTX deficiency may affect CD4+ Tfh cell numbers and/or function.
We measured Tfh cell generation in WT and UTX-TCD mice at day 21 pi to determine the 
effect of UTX on Tfh differentiation during chronic virus infection. Notably, a population of 
CD4+ T cells in WT animals co-expressed the Tfh markers CXCR5 and PD-1 (programmed 
cell death protein 1), while the frequency and total numbers of this population were 
significantly reduced in UTX-TCD mice (Figure 2A). The reduced cellularity was specific 
to the Tfh pathway, as the number of Tbet (TBX21)+ Th1 cells was not impacted by loss of 
UTX (Figure 2B). In addition to the decreased number of Tfh cells, CXCR5+ cells from 
UTX-TCD mice showed significant reduction in the expression of multiple Tfh-related cell 
surface molecules involved in cellular interactions with B cells, including ICOS, which 
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instructs Tfh development through upregulation of BCL-6 (Choi et al., 2011); SLAMF6 
(Ly108), a receptor that sustains signals into Tfh cells via SAP (Sh2d1a), and stimulates GC 
formation (Kageyama et al., 2012); as well as PD-1, OX-40 (CD134 or Tnfrsf4), CD84, and 
CD200 (Figures 2C and S3A-D). During chronic virus infection, Tfh cells co-express IFNγ 
and IL-21 (Elsaesser et al., 2009), and we found that the number of IFNγ+IL-21+ Tfh cells 
was decreased in UTX-TCD mice (Figure 2D). The total number of CXCR5+ BCL-6+ Tfh 
cells was also reduced, without affecting the intensity of BCL-6 staining (Figure S3E,F). 
Thus, UTX-TCD Tfh cells are reduced in number and show decreased expression of Tfh-
related effector molecules during chronic infection.
Since Tfh cells function to induce B cell antibody production in the GCs of lymphoid 
organs, we next determined the effects of T cell UTX deficiency on B cell responses. At day 
21 pi, we detected significant decreases in the frequency and total numbers of Fas+GL7+ GC 
B cells by flow cytometry (Figure 2E). Moreover, immunohistochemical staining for peanut 
agglutinin (PNA)+ GC B cells showed significantly decreased areas of GC B cells relative to 
B220+ follicles in UTX-TCD spleens (Figure 2F). Consistent with the reduction in GC B 
cells, the levels of anti-LCMV total-IgG, IgG1, and IgG2c were decreased in UTX-TCD 
mice at day 21 pi (Figure 2G & S3G). These findings suggest that T cell expression of UTX 
maintains Tfh cell differentiation and subsequent B cell antibody production.
UTX intrinsically affects Tfh cell numbers during late chronic virus infection
Although the data above implicate UTX in Tfh development and subsequent antibody 
production during chronic virus infection, a potential concern is that all T cells in the UTX-
TCD mice lack UTX, including CD8+ T cells, CD4+ T cells, and regulatory CD4+ T cell 
populations. Thus, the effects that we observe for Tfh cells could be an indirect result of the 
immunological environment within the UTX-TCD mice. Alternatively, UTX could have a 
cell-intrinsic role in the differentiation of CD4+ T cells into the Tfh lineage. To distinguish 
between these two possibilities, we performed adoptive transfers of virus-specific WT or 
UTX-TCD naïve CD4+ T cells into wildtype hosts and compared the differentiation of the 
donor cell populations. UTX-TCD mice were crossed with LCMV-specific TCR transgenic 
SMARTA mice (Oxenius et al., 1998) that express the congenic Ly5a (CD45.1) allele to 
generate UTX-TCD SMARTA mice. Splenocytes from WT SMARTA mice or UTX-TCD 
SMARTA mice were adoptively transferred to wildtype Ly5b+ (CD45.2) C57BL/6 mice, 
and recipients were infected with the acute Armstrong strain (Figures S4A) or chronic A22 
strain. The WT and UTX-TCD SMARTA cells were detected in equivalent proportions in 
uninfected control mice, indicating that their engraftment and maintenance was similar in 
the absence of infection (Figure S4B, left). In response to acute Armstrong infection there 
was no difference in expansion of SMARTA CD4+ T cells or their co-expression of CXCR5 
and PD-1 by day 8-9 (Figure S4B-D). In response to chronic A22 virus infection, the WT 
and UTX-TCD SMARTA cells expanded similarly (d8-9) and were maintained equivalently 
at d22-23 (Figure 3A), indicating that T cell accumulation and survival are not grossly 
modulated by UTX. However, by day 22 pi there was a decrease in the frequency and total 
number of CXCR5+PD-1+ UTX-TCD SMARTA Tfh cells (Figures 3B-D). In addition to 
their reduced abundance, the UTX-deficient Tfh cells expressed lower amounts of the Tfh 
effector molecule SLAMF6 at days 8 and 22 pi, and lower ICOS at day 22 pi (Figure 3E). 
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Whether changes in UTX transcript levels over time may modulate Tfh differentiation was 
tested in WT SMARTA cells. UTX mRNA was stable across time during the chronic 
infection and also found at similar levels at day 8 of the acute infection (Figure 3F), 
indicating that differences in UTX mRNA do not correlate with Tfh differentiation in these 
cells. In contrast, BCL-6 expression levels directly correlated with the frequency of Tfh cells 
among the WT SMARTA cells (Figure 3G). Taken together, these data show that UTX has a 
cell-intrinsic function in CD4+ T cells that is crucial for Tfh cell accumulation during an 
ongoing chronic virus infection.
Despite similar WT and UTX-TCD SMARTA Tfh cell numbers at day 8 of the acute and 
chronic infections (Figures 3D & S4D), we observed reduced expression of the Tfh effector 
molecule SLAMF6 in the absence of UTX (Figure 3E), suggesting that Tfh function may be 
altered early during infections. To test this, we analyzed endogenous Tfh differentiation and 
function at day 8 in WT and UTX-TCD mice. We found that Tfh cell numbers were 
equivalent at day 8 of acute and chronic infections (Figure S5A), which was consistent with 
the SMARTA findings (Figure 3D). We also observed reduced expression of SLAMF6 on 
the CXCR5+ cells from the UTX-TCD mice (Figure S5B). T cell UTX deficiency resulted in 
reduced B cell responses, as measured by serum anti-LCMV total IgG, and germinal center 
and plasmablast B cell numbers, during acute and chronic infections (Figures S5C,D). These 
data suggest that even when found at similar quantities, the UTX-deficient Tfh cells are 
qualitatively affected. Importantly, this functional impairment at early and late stages of 
chronic infection is not due to enhanced total Treg or T follicular regulatory cell (Tfr) 
subsets (Figure S5E).
UTX deficiency alters Tfh gene expression via H3K27me3 regulation
To understand how UTX alters global gene expression during Tfh cell specification, we 
performed RNA-seq expression analysis of endogenous, polyclonal CD4+CXCR5+CD62Llo 
Tfh cells that were FACS-sorted from day 21 A22-infected WT and UTX-TCD mice. In 
UTX-TCD compared to WT Tfh cells, we identified 54 genes with significantly reduced 
expression and 34 with increased expression (Figure 4A & Table S1). Among the 
differentially expressed genes in the UTX-TCD Tfh cells, several Tfh-related genes were 
down-regulated while T helper type 1 (Th1)-related genes were up-regulated (Figure 4B). 
Expression of Tfh-related genes such as Icos, Ox-40, Il6ra, and Slamf6 were all significantly 
reduced in UTX-TCD Tfh cells. The decreased mRNA for these genes is consistent with 
decreased protein levels (Figures 2C & S3). In contrast, Th1-associated genes such as 
Eomes, Ccl4, Ccl5, and Ccr2 were significantly enhanced in UTX-TCD Tfh cells (Figure 
4B). Th1 enhancement has been reported to occur concurrently with loss of Tfh signaling 
during viral infection (Ray et al., 2014). These findings suggest that UTX enforces a pattern 
of Tfh gene expression with repression of Th1 genes. Additionally, other genes, such as 
Ahnak, Tnfrsf25, and Thy1, that are associated with T cell homeostasis, activation, or 
proliferation were also affected by the absence of UTX (Haeryfar and Hoskin, 2004; Matza 
and Flavell, 2009; Schreiber and Podack, 2013).
Prevalent UTX-dependent gene activation occurs via H3K27me3 demethylation. To 
determine if the altered gene expression in UTX-TCD cells is due to the loss of UTX-
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mediated histone demethylation, H3K27me3 ChIP-seq was performed on endogenous, 
polyclonal Tfh cells (CD4+CXCR5+CD62Llo) sorted at day 21 pi. EdgeR statistical analysis 
identified all promoter regions (transcription start site +/− 1KB) that experienced 
significantly elevated H3K27me3 in UTX-TCD cells. To facilitate a broad genomic 
comparison of UTX affected genes, we measured H3K27me3 accumulation at the promoters 
of all genes that experienced significantly down-regulated expression in UTX-TCD Tfh 
(Table S1). A subset of genes with reduced expression also demonstrated significant 
accumulation of promoter H3K27me3 (6 of 54 genes: Cd9, Evl, Il6ra, S1pr1, Tnfrsf25, and 
Thy1). The UCSC genome browser H3K27me3 ChIP-seq tracks for these genes are depicted 
in Figure 5A. All of the genes identified in Figure 5A by ChIP-Seq showed increased 
amounts of H3K27 in UTX-TCD cells when analyzed by ChIP-qPCR (Figure 5B). In 
contrast, several genes with promoters containing H3K27me3 (Gata3, Hoxb1, Eomes) in 
WT Tfh cells did not show increases in H3K27me3 accumulation in UTX-TCD Tfh cells 
(Figure 5B and data not shown). The boxplot of log fold change (FC) for H3K27me3 
demonstrates that the overall distribution of genes that were down-regulated in UTX-TCD, 
as revealed by RNA-seq, is significantly increased in H3K27me3 relative to the genes that 
were up-regulated in UTX-TCD cells (p-value=0.021, Figure 5C). H3K27me3 ChIP-qPCR 
confirmed that there was an enriched distribution of H3K27me3 in UTX-TCD down-
regulated genes (p-value=0.008, Figure 5D). Furthermore, UTX ChIP-qPCR demonstrated 
enriched UTX occupancy at the promoters of two targets of UTX H3K27 demethylation 
(Il6ra and Thy1; Figure S6A). Therefore, the genes with elevated H3K27me3 levels in 
UTX-TCD Tfh are likely to be gene-specific UTX dependent targets.
During murine chronic virus infection with LCMV-Clone13, irradiation resistant cells 
produce IL-6 in a biphasic manner, with the second IL-6 peak playing a critical role in virus 
control (Harker et al., 2011). Consistent with that report, LCMV-A22 infection induced 
biphasic IL-6 production with a second peak around day 20 during infection. (Figure S6B). 
The second IL-6 peak acts upon IL-6R on CD4+ T cells to drive Tfh differentiation (Harker 
et al., 2011; Petrovas et al., 2012). Due to its function in Tfh differentiation during the late 
phase of chronic viral infection, Il6ra stood out among genes identified with H3K27me3 
promoter accumulation at day 21 p.i. with LCMV-A22. ChIP-qPCR validated a 3.6 fold 
accumulation of H3K27me3 at the Il6ra promoter in UTX-TCD Tfh relative to WT at day 
21 p.i. (Figure 5B). The dynamics of Il6ra demethylation and expression were assessed 
across a time-course using cells from uninfected mice (naïve; CD62Lhi) and from day 8 
(CD62Llo) and day 21 (CXCR5+CD62Llo) after LCMV-A22 infection. Il6ra was devoid of 
H3K27me3, and high levels of IL6Rα protein were expressed on naïve cells from both WT 
and UTX-TCD mice (Figure 5E-G). Early in LCMV-A22 infection (d8), Il6ra accumulated 
H3K27me3 and there were reduced amounts of IL6Rα protein in both WT and UTX-TCD 
cells. However in the later phase of chronic infection (d21), WT Tfh cells had elevated 
IL6Rα expression while UTX-TCD Tfh cells had enhanced Il6ra H3K27me3 accumulation 
and reduced IL6Rα protein. To determine the functional significance of the reduced IL-6 
receptor expression on UTX-TCD cells, we compared the responsiveness of UTX-TCD and 
WT T cells to IL-6 in vitro. IL-6-induced phosphorylation of STAT3 was unchanged 
between WT and UTX-TCD naïve CD4+ T cells from uninfected mice and effector cells 
from day 8 LCMV-A22 infected mice (Figure S6C-D). However at day 21, the 
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phosphorylation of STAT3 was reduced in UTX-TCD compared to WT T cells following in 
vitro culture with IL-6 (Figure 5H). In contrast, IL-21 stimulated equivalent phospho-
STAT3 levels in WT and UTX-TCD cells, indicating that the defect seen in response to IL-6 
is not due to an inherent defect in STAT3 (Figure 5H). These results suggest that UTX-
mediated H3K27me3 demethylation is a dynamic process that occurs during the course of a 
chronic virus infection to enforce appropriate IL-6Rα expression and downstream function, 
which includes the promotion of Tfh differentiation.
UTX expression is gene-dosage dependent and decreased in Turner Syndrome
Utx escapes X-inactivation in both humans and mice (Greenfield et al., 1998). Thus, UTX is 
expressed by both X chromosomes in females. Whether UTX function in T cells is dosage 
dependent, however, is not known. We investigated the effects of UTX dosage on the 
control of chronic virus infection in mice heterozygous for Utx mutation (Utx+/flLck-Cre; 
UTX-THet). Cohorts of UTX-WT, UTX-THet, and UTX-TCD were given LCMV-A22, and 
viral loads and T cell responses were followed over time. The clearance of LCMV-A22 from 
the serum was delayed in UTX-THet mice compared to WT mice, but the phenotype was 
not as severe as in UTX-TCD mice (Figure 6A). Likewise, the UTX-THet mice showed 
intermediate titres of infectious virus in several tissues at day 55 pi (Figure 6B). The UTX-
TCD mice show reduced Tfh differentiation (Figures 2-3), which likely contributed to the 
delay in resolving LCMV-A22. Similarly, the UTX-THet mice had fewer Tfh cells at day 20 
(Figures 6C & 6D). These data indicate that a 50% reduction in UTX expression diminishes 
the formation or maintenance of Tfh cells and impairs immune protection against a chronic 
virus infection.
UTX gene-dosage dependency is potentially of clinical relevance in humans. Turner 
Syndrome (TS) occurs in females lacking part or all of an X chromosome and is the most 
common sex chromosomal abnormality that affects girls and women. TS is characterized by 
an array of clinical conditions, including recurrent ear infections and alterations in T cell and 
immunoglobulin subsets, though the mechanisms underlying these immune changes are not 
currently known (Cacciari et al., 1981; Jensen et al., 1976; Mock et al., 2000; Stenberg et al., 
1998; Su et al., 2009). Because TS subjects lack at least part of the second sex chromosome, 
decreased expression of X-linked gene(s) that escape X-inactivation may underlie these 
immune alterations (Carrel and Willard, 2005). Importantly, UTX is located on the X 
chromosome and escapes X-inactivation in both mice and humans (Greenfield et al., 1998). 
Given that UTX is subject to gene dosage effects, we reasoned that UTX might be 
haploinsufficient in TS immune cells.
We utilized global gene expression profiling using the Agilent SurePrint G3 Human Gene 
Expression 8×60K Microarray to identify candidate genes with altered expression in TS 
immune cells. Comparison of peripheral blood mononuclear cells (PBMCs) from control 
females to TS subjects with confirmed 45X karyotype showed differential expression of 
1169 unique genes, including 35 that are located on the X chromosome. UTX was among the 
10 genes with the largest decrease in expression in TS subjects (Figure 7A) and the only 
gene among these candidates known to escape X-inactivation (Greenfield et al., 1998). The 
decrease in UTX transcript expression was verified by RT-PCR on cDNA from TS and 
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female control PBMCs (Figure 7B). These findings suggest a potential causative role for 
UTX deficiency in TS immune dysfunction.
We sought to determine if decreased UTX expression in TS might be associated with 
decreases in Tfh cells, as we have observed in mice. As expected, the majority of TS 
individuals had a history of recurrent otitis media (Figure S7A). We first measured the 
frequency of total, naïve (CD45RA+) and antigen experienced (CD45RO+) CD4+ T cells, 
and found no significant differences between controls and TS individuals (Figure 7C-E). 
Circulating CD4+CXCR5+ have been correlated with antibody production in humans, thus 
representing an accessible, surrogate Tfh-like population (Morita et al., 2011; Pallikkuth et 
al., 2012; Simpson et al., 2010). We therefore compared the frequency of circulating CD4+ 
CXCR5+ T cells in non-TS females versus TS subjects. There was a two-fold reduction in 
the frequency of circulating CD4+CXCR5+ cells from TS subjects (Figure 7F,G). The 
expression of IL-6R on CXCR5+ CD4+ T cells was modestly decreased in TS subjects, 
although this difference did not reach statistical significance because of an outlier in the 
control group (Figure S7B). Additionally, the CXCR5+ cells from TS subjects showed a 
trend towards diminished responsiveness to IL-6-induced phosphorylation of STAT3 
compared to cells from controls (Figure S7C). Together, these findings suggest that UTX 
deficiency may contribute to the infection predisposition observed in TS by reducing the 
frequency of the CD4+ CXCR5+ subset.
Discussion
T cell subset differentiation is highly regulated to ensure that the adaptive immune system 
can vigorously fight off diverse pathogens while avoiding immune-mediated pathology. Th 
subtypes are characterized by distinct H3K27me3 epigenetic profiles that reflect subtype 
specific transcriptional programs (Wei et al., 2009). These lineage specific epigenetic 
changes suggest that histone-modifying enzymes are crucial in their differentiation. In this 
study, we identify the H3K27me3 demethylase UTX as a key regulator of CD4+ T cell 
differentiation to the Tfh subset during a chronic virus infection. In the absence of UTX we 
observe decreased numbers of Tfh cells, altered germinal centers, reduced humoral immune 
responses and enhanced virus persistence.
Tfh cells are crucial in vaccine responses and protection from infection via their ability to 
promote B cell antibody production and affinity maturation. Recent data in mice and 
humans have demonstrated that chronic virus infections result in enhanced Tfh 
differentiation (Fahey et al., 2011; Feng et al., 2012; Feng et al., 2011; Lindqvist et al., 
2012). Interestingly, the development of Tfh cells appears to be differentially regulated in 
response to acute versus chronic virus infections. IL-6 and its cognate receptor (IL-6Rα) are 
required for Tfh differentiation during chronic LCMV infection of mice and are strongly 
correlated with Tfh responses following SIV infection of macaques (Harker et al., 2011; 
Petrovas et al., 2012). Our data indicate that UTX-TCD Tfh cell frequency was unchanged 
during acute infection and early during chronic infection (Figures 3, S4, & S5). However, 
the accumulation of UTX-TCD Tfh cells was reduced later during the chronic infection. 
Additionally, our data indicate that the responsiveness of CD4+ T cells towards IL-6 is 
regulated by UTX-mediated H3K27me3 demethylation of the Il6ra promoter during later 
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stages of chronic infection. Together, these findings suggest that epigenetic regulation of 
Il6ra by UTX may underlie the differences seen in acute versus chronic infection.
In addition to the effects of UTX on the number of Tfh cells at later times during chronic 
virus infection, UTX also appears to regulate the function of Tfh cells throughout acute and 
chronic infection. At day 8 pi the number of Tfh cells was equivalent, yet the B cell response 
was decreased in UTX-TCD in comparison with WT mice. One possibility is that T cell 
recruitment into B cell follicles is defective in the absence of UTX. Another possibility is 
that T-B interactions, which are dependent upon the adaptor protein SAP, are disrupted in 
the absence of T cell UTX. We noted a consistent reduction in expression of SLAMF6, 
which promotes T-B interactions and recruits SAP, across all time points in UTX deficient T 
cells. Therefore, UTX mediated regulation of SLAMF6 may be involved in promoting Tfh 
cell functionality. Further experiments are needed to determine at what step T cell help for B 
cells is defective, as well as to test if SLAMF6 or other specific targets of UTX regulate this 
pathway.
Interestingly, IL-6 expression during chronic LCMV infection is biphasic, with an early 
induction followed by silencing and then a second wave of expression a few weeks later 
(Harker et al., 2011). Given that UTX-TCD Tfh cell frequency was unchanged during the 
early stage of chronic infection (Figure 3 and S5), we propose that early robust 
inflammatory signals, potentially including IL-6, are sufficient to induce Tfh cell 
development in the absence of UTX, as T cell expression of IL-6Rα is UTX-independent in 
naïve cells and at day 8 (Figure 5). However, in the context of sustained infection, UTX-
mediated demethylase activity is required to ensure that virus-specific Tfh cells are receptive 
to the second wave of IL-6 expression. Compared to antibody responses to acute infections 
or vaccines, neutralizing antibody to chronic virus infections often emerge following a 
lengthy delay and are thought to require extensive somatic hypermutation of 
immunoglobulin in GCs. Thus, it is plausible that T cell UTX plays a central role in the 
formation of neutralizing antibody during this delayed phase.
Global transcriptome analysis identified multiple genes with reduced expression in UTX-
TCD cells, and a small number of those genes (e.g., Il6ra) had enhanced H3K27me3, 
indicating that UTX demethylase activity contributes to their expression. It was surprising 
that such a small number of genes showed enhanced H3K27me3 and reduced expression in 
the absence of UTX. One explanation for this may be a potential overlap in targets between 
UTX and JMJD3, the other H3K27me3 demethylase expressed in T cells. In addition to the 
genes dependent on UTX-mediated demethylation, the expression of several other Tfh 
lineage genes in UTX-TCD cells were reduced in the absence of H3K27me3 accumulation 
(e.g., Slamf6, Figure 5B). There are two possible explanations for these UTX-dependent 
changes in gene expression. It could be that these genes are not direct targets of UTX 
regulation but are induced by factors, such as activated STAT3, that are downstream of IL-6 
signaling that is potentiated by UTX. Alternatively, it could be that these genes are induced 
by UTX in a demethylase-independent manner, which has been observed in a number of 
developmental settings. For example, UTX, as well as JMJD3, was able to drive IFN-γ and 
other cytokine production in an EL4 lymphoma line through interactions with T-box 
transcription factors and nucleosome remodeling factors (Miller et al., 2010). UTX may act 
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in a similar fashion during Tfh differentiation by interacting with and promoting the activity 
of Tfh-specific transcription factors independently of its H3K27me3 demethylase ability.
Finally, our study of TS subjects suggests a potential role for UTX in human T cells. 
Recurrent ear infections in TS are well-recognized, but the underlying mechanism for this is 
not known (Stenberg et al., 1998). A study seeking to associate recurrent ear infections in 
TS with immune abnormalities did not find major immunological deficiencies in TS patients 
(Stenberg et al., 2004). However, other investigations have demonstrated abnormalities in 
the T cell compartment and the generation of immunoglobulins, suggesting that recurrent ear 
infections might reflect a defect in immune function (Cacciari et al., 1981; Jensen et al., 
1976; Mock et al., 2000). In line with the latter studies, our analysis demonstrates that TS 
immune cells are UTX deficient and the frequency of circulating CD4+ CXCR5+ T cells is 
reduced in TS. A caveat to this result, however, is that circulating CD4+ CXCR5+ T cells 
likely represent a heterogeneous population (He et al., 2013; Locci et al., 2013). 
Interestingly, UTX mutations have recently been described in Kabuki Syndrome, a rare 
congenital disorder in which susceptibility to infections has also been described (Lederer et 
al., 2012). Remarkably, recurrent ear infections also occur in 63% of Kabuki Syndrome 
patients (Matsumoto and Niikawa, 2003). Thus, two independent syndromes associated with 
a loss of UTX function share increased susceptibility to chronic ear infection. Our findings 
describing the role of UTX in CD4+ T cells provide a mechanism for the immune 
dysfunctions in these two syndromes.
Experimental Procedures
See Supplemental Experimental Procedures for details.
Mice
All mouse experimental procedures were approved by the University of North Carolina 
Institutional Animal Care and Use Committee. Utxfl/fl mice were backcrossed to C57BL/6J 
for > 5 generations. These mice were then crossed to Lck-Cre (Hennet et al., 1995) and 
Ly5a+ (CD45.1) SMARTA TCR-transgenic lines that have CD4+ T cells specific for the 
LCMV epitope GP61-80 presented by I-Ab (Oxenius et al., 1998). All mouse experimental 
procedures were approved by the University of North Carolina Institutional Animal Care 
and Use Committee.
Virus
Mice were infected by intraperitoneal injection of 2×105 PFU of LCMV-Armstrong or 
intravenous injection of 2×106 PFU LCMV-A22. LCMV was prepared from BHK cells and 
quantified by plaque assay on Vero cell monolayers.
RNA-seq
RNA was extracted from FACS-sorted CD4+CXCR5+CD62Llo T cells (106 cells total) from 
day 21 pi and purified on oligo(dT) dynabeads for cDNA amplification. Adaptors were 
ligated and 100bp reads were sequenced by the HiSeq 2000 Analyzer located at the Scripps 
DNA Sequencing Facility.
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All human research was approved by the University of North Carolina Institutional Review 
Board, and written informed consent was obtained from all participants. PBMC RNA from 
ten Turner Syndrome subjects and five control female subjects were labeled and hybridized 
to the Agilent SurePrint G3 Human Gene Expression 8×60K Microarray. In the case where 
microarray chips were scanned on different dates, batch effect was identified and removed 
(Partek® Genomics Suite™, St. Louis, MO). See Supplemental Experimental Procedures for 
analysis details.
Adoptive Transfers
Spleen cells were isolated from WT or UTX-TKO Ly5a+ SMARTA TCR transgenic mice. 
The frequency of CD4+ T cells was determined by flow cytometry, and the spleen cells were 
adjusted so that 5×103 Smarta CD4+ T cells were injected into WT C57BL/6 mice 
(Ly5b+Ly5a−) via tail vein injection. The cells were allowed to engraft for 4 days before the 
recipient mice were infected.
Antibody levels
Sera were collected and virus-specific IgG was measured by ELISA using plates coated with 
virus-infected or uninfected BHK lysates (Whitmire et al., 1996). The highest dilution at 
which the OD value reached 1.5 (roughly 50% maximal response) was calculated for each 
sample.
Immunohistochemistry
Formalin-fixed paraffin-embedded spleen sections were stained with fluorescent antibodies 
or peanut-agglutinin and imaged on a Zeiss-710 confocal laser scanning microscope at the 
UNC Microscopy Services Laboratory.
Phospho-STAT3 staining
Mouse splenocytes or human PBMCs were cultured with recombinant mouse or human 
IL-6, respectively (both from Peprotech). The cells were then surface stained, fixed, 
permeabilized with Perm Buffer III (BD Biosciences) and stained with mouse anti-human 
STAT3 (pS727) Clone 49/p-STAT3 (BD Biosciences).
ChIP
FACS-sorted CD4+CXCR5+CD62Llo T cells (2×106 cells per replicate) from day 21 pi were 
crosslinked with 0.6% formaldehyde and sonicated (Bioruptor Sonifier). ChIP was 
performed with anti-H3K27me3 (Abcam ab6002, 2μg) (Rahl et al., 2010). UTX ChIP was 
performed on in vitro differentiated Tfh (Lu et al., 2011) and 1×107 nuclei were subjected to 
micrococcal nuclease digestion (2,000U/ml for 15 minutes at 37 degrees) prior to ChIP with 
UTX antibody (Agger et al., 2007).
Statistics
All bar graphs are presented as mean + SEM. Significance was determined by unpaired 
Students t test. * P < 0.05, ** P <0.01, and *** P <0.001.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1. T cell UTX deficiency increases the persistence of a disseminating viral infection
UTX-TCD and UTX-WT littermate control mice were infected with LCMV-A22.
(A) The viral titer in the serum over time.
(B) The level of infectious virus in the indicated tissues at day 66 pi. The dashed lines 
indicate the level of detection.
(C) Examples of Db/GP33-41 staining of gated CD8+CD4−CD19− T cells (left) and the total 
number of splenic tetramer positive CD8+ T cells at day 21 pi (right).
(D) Examples of PD-1 and Lag-3 staining (left) and their gMFI on gated tetramer positive 
CD8+ T cells (right).
(E) Examples of I-Ab/GP66-77 staining of gated CD4+CD8−CD19− T cells (left) and the 
total number of splenic tetramer positive CD4+ T cells at day 21 pi (right).
All data in this figure are representative of three independent experiments and shown as 
means ± SEM. See also Figures S1 and S2.
Cook et al. Page 18













Figure 2. T cell expression of UTX promotes CD4+ Tfh development and B cell function during a 
chronic viral infection
UTX-TCD and UTX-WT littermate control mice were infected with LCMV-A22 and 
harvested at d21.
(A) Examples of PD-1 and CXCR5 staining on gated CD4+CD8−CD19− T cells (left) and 
the total number of CXCR5+PD-1+ Tfh cells (right).
(B) The total number of T-bet+ CD4+ T cells.
(C) Examples of ICOS and SLAMF6 staining (left) and their gMFI on gated 
CD4+CXCR5+CD8-CD19− Tfh cells (right).
(D) The total number of CD4+ T cells producing IFNγ and IL-21, as measured by ICS.
(E) An example of Fas and GL7 staining on gated B220+ cells (left) and the total number of 
GC B cells (right).
(F) Representative spleen sections stained for B220 and PNA (top), and the percentage of 
the B220+ area that is also PNA+ (bottom).
(G) The serum concentrations of anti-LCMV total IgG, IgG1, and IgG2c.
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Panels A,B,C, E & G are representative of three independent experiments, panel F is of two 
independent experiments, and panel D is of one experiment; all are shown as means + SEM. 
See also Figure S3.
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Figure 3. UTX is required for Tfh differentiation during chronic virus infection
WT or UTX-TCD SMARTA CD4+ cells were transferred to C57BL/6 mice followed by 
infection with LCMV-A22 and analyzed at d8-9 and d22-23 after infection.
(A) The total number of splenic CD4+ Ly5a+ SMARTA cells.
(B) Examples of PD-1 and CXCR5 staining after gating on SMARTA cells.
(C) The frequency of SMARTA cells that are CXCR5+PD-1+.
(D) The total number of SMARTA Tfh cells.
(E) The gMFI of ICOS and SLAMF6 on gated CXCR5+ SMARTA cells.
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(F) The relative levels of UTX mRNA in WT SMARTA cells as assessed by qRT-PCR and 
normalized to Actb mRNA.
(G) The relative levels of BCL-6 mRNA in WT SMARTA cells as assessed by qRT-PCR 
and normalized to Actb mRNA.
All data in this figure are representative of two independent experiments and shown as 
means + SEM. See also Figure S4 & S5.
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Figure 4. Tfh gene expression is altered in UTX-TCD mice
CD4+CXCR5+CD62Llo T cells were FACS sorted from d21 LCMV-A22 infected spleens. 
RNA was prepared from 106 cells and subjected to RNA-sequencing.
(A) An EdgeR analysis of RNA-seq data is presented as Log Fold Change (logFC) of UTX-
TCD relative to WT plotted against log Counts Per Million reads (logCPM). Significant 
(FDR<0.05) differences are illustrated as purple circles. Arrows indicate key genes mis-
regulated in UTX-TCD cells.
(B) The heat map shows individual replicates of WT and UTX RNA-seq expression of Tfh 
or Th1 signature genes. Darker red denotes higher expression. Tfh gene expression is 
reduced in UTX-TCD cells while Th1 gene expression is increased.
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Figure 5. A subset of genes that are misexpressed in UTX-TCD Tfh cells show increased 
H3K27me3, including Il6ra
(A-D) CD4+CXCR5+CD62Llo T cells were FACS sorted from d21 LCMV-A22 infected 
spleens and subjected to H3K27me3 ChIP-seq or ChIP-qPCR.
(A) UCSC genome browser images of H3K27me3 ChIP-seq tracks from d21 LCMV-A22 
infected Tfh at selected promoters demonstrating significant H3K27me3 accumulation in 
UTX-TCD relative to WT.
(B) H3K27me3 ChIP-qPCR verification of d21 LCMV-A22 CD4+CXCR5+CD62Llo T 
cells. ChIP was performed with an IgG control (grey) or H3K27me3 ChIP in WT (black) or 
UTX-TCD cells (white) at indicated genic promoters graphed relative to % input. Npm1 is a 
negative control locus (active gene) and Gata3 is a positive control (H3K27me3 repressed).
(C) EdgeR analysis of promoter region (transcription start site +/− 1KB) H3K27me3 is 
presented as Log Fold Change (logFC) of UTX-TCD relative to WT for all genes that were 
either down-regulated in expression in UTX-TCD (left column) or up-regulated (right 
column) based on RNA-seq. The logFC is normalized relative to the genome average. All 
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genes experiencing significant H3K27me3 enrichment in UTX-TCD Tfh are labeled as red 
dots.
(D) H3K27me3 ChIP-qPCR data was quantified as Log Fold Change (logFC) of UTX-TCD 
relative to WT for select genes that were either down-regulated in UTX-TCD or up-
regulated / unaltered based on RNA-seq analysis. All genes experiencing significant 
H3K27me3 enrichment in UTX-TCD Tfh are labeled as red dots.
(E-F) CD4+ T cells were FACS sorted from d0 (naïve; CD62Lhi), day 8 of LCMV-A22 
(CD62Llo), and day 21 of LCMV-A22 (CXCR5+CD62Llo).
(E) Examples of IL-6Rα staining on WT and UTX-TCD cells at the indicated days.
(F) The gMFI of IL-6Rα on WT and UTX-TCD T cells.
(G) Enrichment of Il6ra promoter proximal H3K27me3 by ChIP-qPCR of WT and UTX-
TCD cells. Data is graphed as fold H3K27me3 enrichment at Il6ra over a control locus 
lacking H3K27me3 (Npm1). .
(H) WT or UTX-TCD SMARTA cells were transferred to WT mice and infected with 
LCMV-A22 as in Figure 3. Splenocytes were harvested on day 22 pi and cultured with the 
indicated cytokines for 30 minutes. The percentage of p-STAT3 positive SMARTA cells 
after the in vitro culture.
All data in this figure are representative of at least two independent experiments and shown 
as means + SEM. See also Figure S6.
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Figure 6. Heterozygous T cell UTX affects virus clearance and Tfh differentiation
WT, UTX-THet, and UTX-TCD mice were infected with LCMV-A22.
(A) The serum viral titer was measured over time.
(B) The level of infectious virus in the indicated tissues at day 55 pi. The dashed lines 
indicate the level of detection.
(C) Spleens were harvested from WT and UTX-THet mice on day 21 pi and the cells were 
analyzed by flow cytometry. Examples of PD-1 and CXCR5 staining on gated 
CD4+CD8−CD19− T cells.
(D) The total number of Tfh Smarta cells (CXCR5+PD-1+).
All data in this figure are representative of two independent experiments and shown as 
means ± SEM.
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Figure 7. UTX expression is decreased in TS peripheral blood mononuclear cells (PBMCs)
(A) Heat map displaying the relative expression levels of the 10 X-linked genes that are 
most depressed in Turner Syndrome (TS) subject PBMCs. Expression levels are z-score 
normalized across rows.
(B) A comparison of array-based UTX expression levels across the subjects. UTX 
expression was normalized to HPRT in control females and TS subjects by quantitative RT-
PCR.
(C) The frequency of CD4+ T cells among all PBMCs. The horizontal bar indicates the 
mean.
(D) The frequency of CD45RA+ cells among gated CD4+ T cells in the blood. The 
horizontal bar indicates the mean.
(E) The frequency of CD45RO+ cells among gated CD4+ T cells in the blood. The 
horizontal bar indicates the mean.
(F) Examples of PBMCs from control of TS subjects that were co-stained for CD4 and 
CXCR5. The ovals identify the CD4+CXCR5+ cells; the numbers indicate their frequency 
among all PBMCs.
(G) The percentage of CD4+CXCR5+ T cells among all PBMCs. The data is shown as mean 
+ SEM; n=5 for healthy controls, n=7 for TS subjects.
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See also Figure S7.
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